// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Blood levels of type-2 innate lymphoid cells in preschool children with acute wheeze

Shah Mohammed Alumgir Hussain - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Type two innate lymphoid cells (ILC2s) in the blood of children with acute asthma

Bethany Barraclough - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Late Breaking Abstract - Peak expiratory flow (PEF) time series can differentiate asthma severity in children

Anja Jochmann - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Monitoring respiratory rate from pulse oximetry during treatment of acute severe wheeze in young children

Paul Seddon - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Prednisolone

Nonadherence with asthma medication in teenagers

Kate Harris - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

The British Lung Foundation asthma management programme - improving children's asthma control

Will Carroll - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Comparative effectiveness of therapies for preschool children with recurrent wheezing

Jonathan Grigg - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Asthma

N/A

Late Breaking Abstract - Comparison of the blood transcriptomic profiles of adults and children from the U-BIOPRED asthma study

Karen Affleck - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Using remote directly observed therapy (R-DOT) for optimising asthma therapy

Michael Shields - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

A European centre study on the utility and safety of EBUS-TBNA in a paediatric population

Haider Al-Najjar - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Utility of open surgical lung biopsy in children

Aditi Sinha - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - Respiratory impairement in children with sickle cell anemia (SCA): differences between the UK and Nigeria

Michele Arigliani - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Sickle cell anemia

N/A

Is severe infantile bronchiolitis associated with severe childhood asthma? A whole population linkage study

Stephen Turner - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Homozygosity for the FCER2 gene is associated with an increased use of leukotriene receptor antagonists

Patricia Soares - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Spanish version of the Quality of Life questionnaires for patients with Primary Ciliary Dyskinesia

Ana Reula Martin - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

Late Breaking Abstract - Physical activity trajectories and lung function at 15 years (ALSPAC study)

Cline Roda - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evolution of Primary Ciliary Dyskinesia (PCD) diagnostic testing in Europe

Florian Halbeisen - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

Towards standardized follow-up care for patients with Primary Ciliary Dyskinesia (PCD)

Myrofora Goutaki - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

New portable nasal nitric oxide (nNO) analyser differentiates primary ciliary dyskinesia (PCD) from healthy individuals

Jane Lucas - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

Nitric oxide

Ten years’ experience of Primary Ciliary Dyskinesia Diagnostic Testing

Bruna Rubbo - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

Copyright © 2026. QuantiNova All rights reserved